Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Cellectar Biosciences
CLRB
$20.5M
| $57K | ﹤0.01% |
723
-1,410
| -66% | -$83K |
|
3377
Castor Maritime
CTRM
$20.3M
| $57K | ﹤0.01% |
13,140
-940
| -7% | -$4.16K |
|
3378
Journey Medical
DERM
$176M
| $57K | ﹤0.01% |
20,900
+9,400
| +82% | +$21K |
|
|
IMA
3379
ImageneBio Inc
IMA
$64.9M
| $57K | ﹤0.01% |
1,091
-84
| -7% | -$5.06K |
|
|
SANW
3380
DELISTED
S&W Seed Co
SANW
| $57K | ﹤0.01% |
2,685
-179
| -6% | -$3.59K |
|
|
CONN
3381
DELISTED
Conn's Inc.
CONN
| $57K | ﹤0.01% |
14,412
-145,400
| -91% | -$604K |
|
|
AAU
3382
DELISTED
Almaden Minerals Ltd
AAU
| $57K | ﹤0.01% |
390,966
-267,430
| -41% | -$36.1K |
|
|
VRPX
3383
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
| $57K | ﹤0.01% |
284
-73
| -20% | -$16.1K |
|
3384
Zevia
ZVIA
$124M
| $56K | ﹤0.01% |
+25,200
| New | +$74.1K |
|
3385
InspireMD
NSPR
$33.7M
| $55K | ﹤0.01% |
16,700
+2,500
| +18% | +$7.98K |
|
|
SONN
3386
DELISTED
Sonnet BioTherapeutics
SONN
| $55K | ﹤0.01% |
2,381
+711
| +43% | +$37.4K |
|
|
MVLA
3387
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $55K | ﹤0.01% |
+102,045
| New | +$131K |
|
3388
Santander
BSBR
$42.5B
| $54K | ﹤0.01% |
10,500
-44,700
| -81% | -$253K |
|
3389
Myomo
MYO
$41.7M
| $54K | ﹤0.01% |
48,200
-38,698
| -45% | -$32.9K |
|
|
AGPU
3390
Axe Compute Inc
AGPU
$103M
| $54K | ﹤0.01% |
1,125
-133
| -11% | -$9.22K |
|
|
TFFP
3391
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $54K | ﹤0.01% |
6,220
+2,200
| +55% | +$20.6K |
|
3392
Compass Therapeutics
CMPX
$357M
| $53K | ﹤0.01% |
+26,800
| New | +$66.3K |
|
3393
NexGel
NXGL
$3.88M
| $53K | ﹤0.01% |
25,031
-1,000
| -4% | -$2.17K |
|
|
VAPO
3394
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $53K | ﹤0.01% |
20,954
-7,187
| -26% | -$22.5K |
|
|
CWBR
3395
DELISTED
CohBar, Inc. Common Stock
CWBR
| $53K | ﹤0.01% |
17,160
+3,800
| +28% | +$11.2K |
|
|
MF
3396
DELISTED
Missfresh Limited American Depositary Shares
MF
| $53K | ﹤0.01% |
+58,147
| New | +$55.6K |
|
|
DPSI
3397
DELISTED
DecisionPoint Systems, Inc.
DPSI
| $52K | ﹤0.01% |
+10,475
| New | +$58.5K |
|
3398
Moleculin Biotech
MBRX
$2.89M
| $51K | ﹤0.01% |
321
-19
| -6% | -$3.93K |
|
3399
PepGen
PEPG
$133M
| $51K | ﹤0.01% |
+10,000
| New | +$63.8K |
|
3400
BiomX
PHGE
$1.97M
| $51K | ﹤0.01% |
761
-268
| -26% | -$19.9K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.